State of Wisconsin Investment Board
QNCX icon

State of Wisconsin Investment Board’s Quince Therapeutics QNCX Stock Holding History

State of Wisconsin Investment Board’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-374
Closed -$47.7K – 2576
2022
Q4 		$47.7K Sell
374
-143
-28% -$23.9K ﹤0.01% 2402
2022
Q3 		$138K Sell
517
-240
-32% -$91.4K ﹤0.01% 2471
2022
Q2 		$336K Buy
757
+175
+30% +$124K ﹤0.01% 2273
2022
Q1 		$720K Buy
582
+476
+449% +$648K ﹤0.01% 1715
2021
Q4 		$266K Sell
106
-17
-14% -$104K ﹤0.01% 2033
2021
Q3 		$2.25M Buy
123
+17
+16% +$270K ﹤0.01% 1256
2021
Q2 		$1.12M Hold
106
– – ﹤0.01% 1420
2021
Q1 		$760K Sell
106
-7
-6% -$50.4K ﹤0.01% 1446
2020
Q4 		$625K Sell
113
-14
-11% -$124K ﹤0.01% 1460
2020
Q3 		$1.26M Buy
127
+34
+37% +$309K ﹤0.01% 1245
2020
Q2 		$857K Buy
93
+5
+6% +$45.8K ﹤0.01% 1268
2020
Q1 		$803K Buy
88
+66
+300% +$651K ﹤0.01% 1240
2019
Q4 		$247K Buy
+22
New +$133K ﹤0.01% 1568

Other funds holding QNCX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State of Wisconsin Investment Board's QNCX Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of Quince Therapeutics (QNCX) in Q1 2023, closing a stake of 374 shares — an estimated $47.7K sold.

State of Wisconsin Investment Board first reported a position in QNCX in Q4 2019 and held it in 13 quarters. The position peaked at $2.25M in Q3 2021. 42 funds tracked by Wall St. Rank hold QNCX as of Q1 2023.

  • State of Wisconsin Investment Board reported no remaining Quince Therapeutics position as of Q1 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 374 Quince Therapeutics shares in Q1 2023, an estimated $47.7K.
  • State of Wisconsin Investment Board first reported a position in Quince Therapeutics in Q4 2019 and held it in 13 quarters.
  • State of Wisconsin Investment Board's Quince Therapeutics position peaked at $2.25M in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.